-
Mashup Score: 1Coadministration of CD19 and CD22-Directed CAR T-cell Therapy Elicits Durable Remissions in Pediatric Patients With B-ALL - 1 year(s) ago
Coadministration CD19- and CD22-directed CAR T-cell therapy produced relatively durable remissions in children with high-risk hematologic or isolated extramedullary relapse of B-acute lymphoblastic leukemia.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 05-Year Survival and Cure Fraction Estimates for Childhood Cancer in Europe From 2000 to 2014 EUROCARE-6 - The ASCO Post - 1 year(s) ago
By Matthew Stenger Posted: 11/28/2022 12:17:00 PM Last Updated: 11/28/2022 12:57:23 PM As reported in The Lancet Oncology by Botta et al, the population-based EUROCARE-6 study has shown an improvement in 5-year survival rates and estimated cure fractions across patients with childhood cancers diagnosed…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Coadministration of CD19 and CD22-Directed CAR T-cell Therapy Elicits Durable Remissions in Pediatric Patients With B-ALL - 1 year(s) ago
Coadministration CD19- and CD22-directed CAR T-cell therapy produced relatively durable remissions in children with high-risk hematologic or isolated extramedullary relapse of B-acute lymphoblastic leukemia.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Jesus Cepero, PhD, RN, highlights the value of holistic care environments in pediatric oncology.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Jesus Cepero, PhD, RN, highlights the value of holistic care environments in pediatric oncology.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia - 2 year(s) ago
Li et al address the role of T-cell immunity on Ph+ acute lymphoblastic leukemia (ALL) outcomes. Using a mouse model, they show that T cells are necessary to ma
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Hispanic children with high-risk neuroblastoma had worse survival outcomes than other children with the disease despite receiving treatment on clinical trials with standardized protocols, according to study results.Researchers observed the disparities even after controlling for disease-related factors.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Brentuximab regimen effective for younger patients with advanced-stage Hodgkin lymphoma - 2 year(s) ago
CHICAGO — Combining brentuximab vedotin with a chemotherapy regimen as first-line therapy conferred an objective response in 88% of younger patients with newly diagnosed advanced-stage classical Hodgkin lymphoma, study results show.Data from the phase 1/phase 2 study presented at ASCO Annual Meeting suggest that the regimen — already FDA-approved for the same indication as first-line
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Childhood Cancer Awareness Month: Therapies exhibit efficacy for glioma, sarcoma, lymphoma - 2 year(s) ago
September is Childhood Cancer Awareness Month.The campaign is intended to spotlight the types of cancer that largely affect children, draw attention to survivorship issues, and raise funds for research and family support.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Childhood Cancer Awareness Month: Therapies exhibit efficacy for glioma, sarcoma, lymphoma - 2 year(s) ago
September is Childhood Cancer Awareness Month.The campaign is intended to spotlight the types of cancer that largely affect children, draw attention to survivorship issues, and raise funds for research and family support.
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Coadministration of CD19 and CD22-Directed CAR T-cell Therapy Elicits Durable Remissions in Pediatric Patients With B-ALL #oncology #nursing #leusm #pediatriconcology https://t.co/xFdDDqfr2T